cgp 12177 has been researched along with Disease Exacerbation in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiriazis, H | 1 |
| Tugiono, N | 1 |
| Xu, Q | 1 |
| Gao, XM | 1 |
| Jennings, NL | 1 |
| Ming, Z | 1 |
| Su, Y | 1 |
| Klenowski, P | 1 |
| Summers, RJ | 1 |
| Kaumann, A | 1 |
| Molenaar, P | 1 |
| Du, XJ | 1 |
1 other study available for cgp 12177 and Disease Exacerbation
| Article | Year |
|---|---|
Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.
Topics: Adrenergic beta-Antagonists; Animals; Binding Sites; Cardiomegaly; Disease Models, Animal; Disease P | 2013 |